Latest news
FDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 00:45:35 GMTExperts Debate PD-1 Rechallenge After ICI Progression in RCC - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 20:05:40 GMTOff-Label Targeted Therapy Presents a Parallel Path to Trials in Sarcomas - Targeted OncologyTargeted Oncology · Mon, 03 Aug 2026 15:07:49 GMT